| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 15 |
| 1 | FOLIC ACID | 3 |
| 2 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 3 |
| 3 | ARIPIPRAZOLE | 2 |
| 4 | CISPLATIN | 2 |
| 5 | ENOXAPARIN SODIUM | 2 |
| 6 | METHYLPHENIDATE HYDROCHLORIDE | 2 |
| 7 | PALIPERIDONE PALMITATE | 2 |
| 8 | 0XYGEN | 1 |
| 9 | ACYCLOVIR | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAPRODUSTAT | 1 | 0.0005 |
| 1 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 2 | VORINOSTAT | 1 | 0.0005 |
| 3 | IPRATROPIUM BROMIDE AND ALBUTEROL | 1 | 0.0004 |
| 4 | ECULIZUMAB | 15 | 0.0003 |
| 5 | FENFLURAMINE | 1 | 0.0002 |
| 6 | ROFLUMILAST | 1 | 0.0001 |
| 7 | TETRABENAZINE | 1 | 0.0001 |
| 8 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 3 | 0.0001 |
| 9 | GOLIMUMAB | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 15 |
| 1 | Atypical Antipsychotic [EPC] | 3 |
| 2 | Vitamin B12 [EPC] | 3 |
| 3 | Vitamin C [EPC] | 3 |
| 4 | Vitamin D [EPC] | 3 |
| 5 | Corticosteroid [EPC] | 2 |
| 6 | Loop Diuretic [EPC] | 2 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| 8 | Platinum-based Drug [EPC] | 2 |
| 9 | Androgen Receptor Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Complement Inhibitor [EPC] | 15 | 0.0003 |
| 3 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 9 | Cardiac Glycoside [EPC] | 1 | 0.0000 |